MIDARP at CCNY
CCNY 的 MIDARP
基本信息
- 批准号:7234457
- 负责人:
- 金额:$ 42.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-01 至 2010-11-30
- 项目状态:已结题
- 来源:
- 关键词:AmericanAreaBiochemistryBiologicalBiological SciencesBiologyBiomedical EngineeringBiophysicsBrain DiseasesCCL7 geneCareer ChoiceCell NucleusChemistryCitiesClassificationCocaineCollaborationsCommitCore FacilityDedicationsDevelopmentDopamine D1 ReceptorDrug abuseEducationEducational workshopEnvironmentExposure toExtramural ActivitiesFacultyFinancial SupportFosteringFunctional disorderFundingFutureGoalsImmigrantIndividualInstitutionInvestigationLaboratoriesLeadershipLocationMAP Kinase GeneMeasuresMentorsMinorityMissionMolecularMolecular BiologyN-Methyl-D-Aspartate ReceptorsNational Institute of Drug AbuseNeurobiologyNeuronsNew YorkNumbersOperative Surgical ProceduresParticipantPerinatal ExposurePharmacologyPhysiologyPopulationPositioning AttributeProductivityProgram EvaluationPsychologyRecording of previous eventsResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch TrainingResourcesSchoolsScienceScientistScoreSecureSocial SciencesSolidStructureStudentsSupport of ResearchTrainingTraining ProgramsTraining SupportTranscendUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesaddictionbasecareercollegedesigndesiredrug of abuseexperienceimprovedin uterointerestmedical schoolsneurochemistryprenatalprogramsresearch and developmentscience educationsocialstructural biologysuccesssymposium
项目摘要
DESCRIPTION (provided by applicant):
CCNY, the science flagship of the CUNY is heavily (75%) involved in educating students from underrepresented minority populations. It is our goal to develop a program at CCNY that draws on existing strengths and focuses and promotes investigations on drug abuse. Our clear aim is to encourage entry of young minority undergraduates and graduate scholars to a career in drug abuse research. The program is thematically focused on the long-term sequel of in utero exposure to cocaine. The neurobiological investigations encompass research on molecular, cellular, and neurochemical effects of exposure to cocaine. The program includes active research faculty, educators specializing in drug abuse graduate and undergraduate research students who share interest in the neurobiology of stimulants and in understanding addiction as a brain disease. The aims of the application are to enhance the breadth of research at CCNY that focuses on the neurobiology of drugs of abuse. The program is also designed to develop individual research projects and to stimulate interest of other faculty and students in research on drug abuse. The overall aim of this program is to facilitate the career development of minority undergraduate and graduate students who will mature into independent investigators of the future. The specific projects proposed are: 1. MAPK in in utero cocaine-induced abnormal neuron differentiation. 2. GSK3beta in prenatal cocaine-induced D1 dopamine receptor dysfunction and dendritic elongation. 3. Prenatal cocaine alterations of NMDA receptor assembly. 4. Protection against the glutametergic effects of in utero cocaine. The PI is an established drug abuse researcher with over 30 years experience. He and other senior faculty will serve as mentors to junior scientists. As a group the faculty are extremely experienced in attracting and mentoring young minority scholars to research. The Institution has committed significant financial support to help secure the success of this program that aims to enhance interest in minorities in the choice of career in drug abuse research.
描述(由申请人提供):
CCNY,CUNY的科学旗舰店大量(75%)参与教育来自代表性不足的少数群体的学生。我们的目标是在CCNY开发一项计划,该计划借鉴了现有的优势,重点并促进对药物滥用的调查。我们的明确目的是鼓励年轻的少数族裔大学生和研究生学者从事药物滥用研究的职业。该程序主题关注子宫内对可卡因的长期续集。神经生物学研究涵盖了暴露于可卡因的分子,细胞和神经化学作用的研究。该计划包括积极的研究教师,专门从事药物滥用研究生的教育工作者以及对兴趣兴趣的兴趣兴趣的兴趣以及将成瘾视为脑部疾病的兴趣。该应用程序的目的是增强CCNY的研究广度,该研究的重点是滥用药物的神经生物学。该计划还旨在开发单个研究项目,并激发其他教职员工和学生对药物滥用研究的兴趣。该计划的总体目的是促进少数本科生和研究生的职业发展,他们将成为未来的独立调查员。提出的特定项目是:1。MAPKIN子宫可卡因诱导的异常神经元分化。 2。产前可卡因诱导的D1多巴胺受体功能障碍和树突延伸的GSK3Beta。 3。NMDA受体组件的产前可卡因改变。 4。防止子宫可卡因的谷氨酸效应。 PI是一名拥有30多年经验的著名药物滥用研究人员。他和其他高级教师将担任初级科学家的导师。作为一个小组,该教师在吸引和指导少数民族学者研究方面非常有经验。该机构已提供了大量的财政支持,以帮助确保该计划的成功,旨在增强对少数民族在药物滥用研究中的职业选择的兴趣。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EITAN FRIEDMAN其他文献
EITAN FRIEDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EITAN FRIEDMAN', 18)}}的其他基金
DOPAMINE-LINKED PHOSPHOINOSITIDE METABOLISM IN BRAIN
脑中多巴胺连接的磷酸肌醇代谢
- 批准号:
2839337 - 财政年份:1998
- 资助金额:
$ 42.39万 - 项目类别:
PRENATAL COCAINE AND DOPAMINE RECEPTOR SIGNALING
产前可卡因和多巴胺受体信号传导
- 批准号:
6175490 - 财政年份:1998
- 资助金额:
$ 42.39万 - 项目类别:
PRENATAL COCAINE AND DOPAMINE RECEPTOR SIGNALING
产前可卡因和多巴胺受体信号传导
- 批准号:
6549360 - 财政年份:1998
- 资助金额:
$ 42.39万 - 项目类别:
相似国自然基金
区域医疗一体化对基层医疗机构合理用药的影响及优化策略——基于创新扩散理论
- 批准号:72304011
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
面向有限监督信息的脑影像感兴趣区域分割及应用
- 批准号:62376123
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
壳聚糖-没食子酸“共价牵手”协同焦磷酸盐“区域保护”调控肌原纤维蛋白凝胶特性的分子机制研究
- 批准号:32302110
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
双区域自然对流耦合模型的高效数值方法研究
- 批准号:12361077
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
典型中小城市区域暴雨积水动态过程集合量化智能解析研究
- 批准号:52379008
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Division of Chemical Toxicology Symposia at the 266th National ACS Meeting
第266届全国ACS会议化学毒理学研讨会分部
- 批准号:
10753870 - 财政年份:2023
- 资助金额:
$ 42.39万 - 项目类别:
Bacterial metabolism of catechol-O-methyltransferase inhibitors alters drug efficacy and toxicity
儿茶酚-O-甲基转移酶抑制剂的细菌代谢改变药物疗效和毒性
- 批准号:
10606184 - 财政年份:2023
- 资助金额:
$ 42.39万 - 项目类别:
2023 Muscle: Excitation-Contraction Coupling Gordon Research Conference and Gordon Research Seminar
2023肌肉:兴奋-收缩耦合戈登研究会议暨戈登研究研讨会
- 批准号:
10606049 - 财政年份:2023
- 资助金额:
$ 42.39万 - 项目类别:
Discovery of allosteric activators of phospholipase C-gamma2 to treat Alzheimer's disease
发现用于治疗阿尔茨海默病的磷脂酶 C-gamma2 变构激活剂
- 批准号:
10901007 - 财政年份:2023
- 资助金额:
$ 42.39万 - 项目类别:
Diagnostic aptamer reagents to develop multi-analyte blood test for pre-clinical, mild and moderate Alzheimer's disease
诊断适体试剂用于开发针对临床前、轻度和中度阿尔茨海默病的多分析物血液检测
- 批准号:
10597840 - 财政年份:2023
- 资助金额:
$ 42.39万 - 项目类别: